It’s a SNaP: new technique paves way for scalable therapeutic nanoparticle manufacturing


An NYU Tandon research team led by Assistant Professor Nathalie Pinkerton has developed Sequential NanoPrecipitation (SNaP), a breakthrough in drug delivery manufacturing. The technique improves upon existing methods by separating particle core formation and stabilization steps, enabling production of both nano and microparticles. "One of the biggest barriers to translating many of these precise medicines is the manufacturing. With SNaP, we're addressing that challenge head-on," says Pinkerton. Using 3D-printed mixers, SNaP offers better size control and democratizes access to this technology.